Citation Impact
Citing Papers
Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)
2013
Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors
2017
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients
2016
Metastasis: from dissemination to organ-specific colonization
2009 Standout
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
2017
Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
2010
Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides
2019
Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
2014
Cancer treatment and survivorship statistics, 2022
2022 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Second-Line Treatment With a Combination of Continuous 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Conti-Fam) in Gemcitabine-Pretreated Pancreatic and Biliary Tract Cancer
2009
Breast cancer
2016 Standout
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
2014 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
2012
Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials
2013
High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma
2010
Macrophages in immunoregulation and therapeutics
2023 Standout
Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force
2015
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines
2015 StandoutNobel
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas
2004
Epigenetics in Cancer
2008 Standout
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
Pancreatic Adenocarcinoma
2014 Standout
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
2010
Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects
2015
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Recent Advances in the Treatment of Breast Cancer
2018
Treatment for the endocrine resistant breast cancer: Current options and future perspectives
2017
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
K‐ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment
2007
Primary brain tumours in adults
2012 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Pancreatic Cancer
2010 Standout
Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes
2021
Liposomes as nanomedical devices
2015 Standout
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly
2007
5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma
2011
The PI3K Pathway in Human Disease
2017 Standout
A Decade of Progress in Lymphoma: Advances and Continuing Challenges
2010
ROS and the DNA damage response in cancer
2018 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
2009
Primary CNS Lymphoma in Immunocompetent Patients
2009
Chemotherapy for advanced non-small cell lung cancer in the elderly population
2015
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016
Hodgkin lymphoma: 2018 update on diagnosis, risk‐stratification, and management
2018
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Breast Cancer Statistics, 2022
2022 Standout
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Metastatic Pancreatic Cancer 2008: Is the Glass Less Empty?
2008
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Breast Cancer Treatment
2019 Standout
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
2007
Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire
2008
Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review
2013
Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
2008
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
2014 Standout
Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001
2008
Guidelines for the management of thyroid cancer
2014 Standout
Nanooncology: The future of cancer diagnosis and therapy
2013
Management of Advanced Pancreatic Cancer with Gemcitabine Plus Erlotinib: Efficacy and Safety Results in Clinical Practice
2013
CTLA-4 and PD-1 Pathways
2015 Standout
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
2005
Works of Roberto Bordonaro being referenced
HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
2016
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer
2011
Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial
2004
Rationale and Design of MILES-3 and MILES-4 Studies: Two Randomized Phase 3 Trials Comparing Single-Agent Chemotherapy Versus Cisplatin-Based Doublets in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
2013
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice
2007
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
2013
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
2005
Long-Term Follow-Up Analysis of HD9601 Trial Comparing ABVD Versus Stanford V Versus MOPP/EBV/CAD in Patients With Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study From the Intergruppo Italiano Linfomi
2011
Temozolomide as salvage treatment in primary brain lymphomas
2007
Efficacy and Safety of Zoledronic Acid in Patients with Breast Cancer Metastatic to Bone: A Multicenter Clinical Trial
2006
ABVD Versus Modified Stanford V Versus MOPPEBVCAD With Optional and Limited Radiotherapy in Intermediate- and Advanced-Stage Hodgkin's Lymphoma: Final Results of a Multicenter Randomized Trial by the Intergruppo Italiano Linfomi
2005
Abstract S4-07: BELLE-3: A phase III study of buparlisib + fulvestrant in postmenopausal women with HR+, HER2–, aromatase inhibitor-treated, locally advanced or metastatic breast cancer, who progressed on or after mTOR inhibitor-based treatment
2017